Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/28/2022
China Approves Takeda's Lung Cancer Drug Brigatinib
3/28/2022
BRICS Launches Vaccine R&D Center
3/25/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (57...
3/25/2022
Drug R&D and Product Registration News Digest March 2022 (4)
3/24/2022
Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chine...
3/24/2022
Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...
3/24/2022
Eli Lilly/Innovent Announce Lung Cancer Drug Rejection by FDA Citing...
3/24/2022
What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)
3/24/2022
New Use Claims in China - Santen Pharma v. Jiangsu Hengrui Medicine
3/24/2022
Preplanned Studies: Disease Burden of Pancreatic Cancer — China, 1990...
3/24/2022
Bracing for Volume-Based Procurement in China (Simon Kucher)
3/24/2022
Hong Kong Remained Asia's Largest Biotech Fundraising Hub in 2021 (Pha...
3/23/2022
PharmCube: Review of Global and Chinese Cross-border Biopharma Transac...
3/23/2022
MOST Releases the Implementation Rules for the Regulations on the Mana...
3/22/2022
NMPA Solicits Comments on the Draft of GSP's Appendix for Quality Cont...
3/22/2022
Transcenta Announces Global Clinical Collaboration with BMS to Evaluat...
3/22/2022
PharmaDJ's China Deals Tracker: February 2022
3/22/2022
The Evolving Treatment Paradigm of Lung Cancer in China (ScienceDirect...
3/22/2022
China Biotech Firms Stunned by US Drug Trial U-Turn (Asia Financial)
3/21/2022
As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
3/21/2022
Bavarian Nordic and Nuance Pharma Enter License for RSV Vaccine for ...
3/21/2022
China's Triastek and Siemens Strive to Accelerate Digital Transformati...
3/20/2022
FT: China Plans Audit Concession in Face of US Delisting Threat
3/18/2022
Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...
3/18/2022
EdiGene Licenses from BCH the Methods and Compositions for Boosting Fe...
3/18/2022
Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021
3/18/2022
Drug R&D and Product Registration News Digest March 2022 (3)
3/18/2022
Recent Executive Moves
3/17/2022
Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...
3/16/2022
Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
Page:
90
/
719
Total number of articles:
21546
:
[First]
[<<]
[88]
[89]
[90]
[91]
[92]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit